Техническая Спецификация для HP 88XL Yellow Officejet Ink Cartridge C9393AE#301
Модели
C9393AE#301
SAFETY DATA SHEET
1-(2-hydroxyethyl)-2-pyrrolidone
Inhalation may result in respiratory irritation.
2-pyrrolidone
Inhalation may result in respiratory irritation.
Aliphatic diol
Inhalation may result in respiratory irritation.
Substituted napthalenesulfonate salt #13
Inhalation may result in respiratory irritation.
space
Inhalation
space
1-(2-hydroxyethyl)-2-pyrrolidone
Ingestion may result in nausea, vomiting and diarrhea.
2-pyrrolidone
Ingestion may result in nausea, vomiting and diarrhea.
space
Ingestion
space
Potential routes of overexposure to this product are skin and eye contact
Inhalation of vapor and ingestion are not expected to be significant routes of exposure for this
product under normal use conditions.
product under normal use conditions.
Complete toxicity data are not available for this specific formulation.
Potential health effects
Routes of exposure
space
None known.
Chronic health effects
space
None of the components present in this formulation at concentrations equal to or greater than
0.1% are listed by EU, MAK, IARC, NTP or OSHA.
0.1% are listed by EU, MAK, IARC, NTP or OSHA.
Carcinogenicity
space
Physical hazards
Not classified as a physical hazard.
space
Health hazards
Not classified as a health hazard.
space
Environmental hazards
Not classified as an environmental hazard.
space
This yellow ink is not classified according to EU Directive 1999/45/EC.
Other information
space
Component/substance
EU classification
CAS number
Water
231-791-2
EU number
% by
weight
weight
> 70
7732-18-5
Aliphatic diol
Proprietary
< 10
Proprietary
1-(2-hydroxyethyl)-2-pyrrolidone
222-359-4
< 10
3445-11-2
.
3. COMPOSITION/INFORMATION ON INGREDIENTS
space
2-pyrrolidone
R36/38
210-483-1
< 7.5
616-45-5
Substituted napthalenesulfonate salt #13
Proprietary
< 5
Proprietary
space
Composition comments
This ink supply contains an aqueous ink formulation.
This product has been evaluated using criteria specified in the EU Directives 67/548/EEC and
1999/45/EC, as amended.
For the full text of the R phrases mentioned in this Section, see Section 16.
This product has been evaluated using criteria specified in the EU Directives 67/548/EEC and
1999/45/EC, as amended.
For the full text of the R phrases mentioned in this Section, see Section 16.
space
Inhalation
Remove to fresh air. If symptoms persist, get medical attention.
.
4. FIRST AID MEASURES
space
Skin contact
Wash affected areas thoroughly with mild soap and water. Get medical attention if irritation
develops or persists.
develops or persists.
space
Eye contact
Do not rub eyes. Immediately flush with large amounts of clean, warm water (low pressure)
for at least 15 minutes or until particles are removed. If irritation persists get medical
attention.
for at least 15 minutes or until particles are removed. If irritation persists get medical
attention.
space
Creation date 30-Apr-2003
Material name C9393A
Version number 1
SDS UK
2 / 6